Peculiarities of the chemodrug resistance of M. tuberculosis to antituberculous medications among children and adolescents from multidrugresistant tuberculous focies
M.I. Sakhelashvili, O.P. Kostyk, O.I. Sakhelashvili–Bil, Z.I. Piskur, J.J. Didyk
Tuberculosis Lung Diseases HIV Infection · 2022-06
Abstract
Objective — to study the peculiarities of the resistance of M. tuberculosis (MTB) to antimycobacterial drugs (AMBD) among children and adolescents living in multidrug-resistant tuberculous focies.
 Materials and methods. 246 children were examined, 145 of them had drug-resistant tuberculosis (TB), 101 children — susceptible form of the specific process, and 102 adult patients who became the source of the disease. Microbiological study in children, adolescents and adults included: detection of MTB in sputum by smear microscopy, seeding on Levenstein—Jensen medium, typing of isolated MTB on BACTEC MGIT 960, determination of drug susceptibility test of MTB strains to AMBD I and II lines, and molecular genetic testing of sputum, including the Gene Xpert MTB/RIF method and the Hain Lifescience linear probe analysis.
 Results and discussion. Researches show that children under one year of age (29.8 %) and up to 4 years of age (73.1 %) are the most vulnerable to TB in the multidrug-resistant tuberculous focies. Study of the resistance profile of MTB in multidrug-resistant foci was found almost complete coincidence of the profile of the resistance of MTB in children with a source of infection. In particular, children from contact compared with sick adolescents are in 3.5 times more likely to be resistant to the combination of HRS, in 2.7 times — to HR, in 1.8 times — to HRE, in 2.7 times less often — to HRESZ, in 1.6 times — to HRES. In adolescents resistance is most often found to the combination of HRSE (66.1 %), HRESZ (13.6 %), in contrast to the source of TB infection and children. Extensive drug resistance is 2.8 times more common in adolescents than in children (14.1 % vs. 5.0 %, p > 0.01).
 Conclusions. Researches have shown a high risk of MDR-TB of lungs among children (42.7 %) from multidrug-resistant tuberculous focies. This indicates the need to improve the methods of obtaining respiratory samples to determine the susceptibility/resistance of MTB to AMBD. In the centers of multidrug-resistant tuberculosis infection, more than a third of children (35.8 %) were not vaccinated in the maternity hospital and no chemoprophylaxis was prescribed for contact persons.
MeSH terms
- Tuberculosis
- Medicine
- Sputum
- Multiple drug resistance
- Drug resistance
- Mycobacterium tuberculosis
- Internal medicine